PBV Stock Overview
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Prestige Consumer Healthcare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$76.50 |
| 52 Week High | US$85.00 |
| 52 Week Low | US$57.50 |
| Beta | 0.46 |
| 1 Month Change | -6.14% |
| 3 Month Change | 1.32% |
| 1 Year Change | 13.33% |
| 3 Year Change | 54.23% |
| 5 Year Change | 156.71% |
| Change since IPO | 457.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| PBV | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.7% | 2.3% |
| 1Y | 13.3% | -11.5% | 16.5% |
Return vs Industry: PBV exceeded the German Pharmaceuticals industry which returned -10.7% over the past year.
Return vs Market: PBV underperformed the German Market which returned 17.2% over the past year.
Price Volatility
| PBV volatility | |
|---|---|
| PBV Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 4.2% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in DE Market | 12.0% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: PBV has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PBV's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 570 | Ron Lombardi | www.prestigebrands.com |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal.
Prestige Consumer Healthcare Inc. Fundamentals Summary
| PBV fundamental statistics | |
|---|---|
| Market cap | €3.81b |
| Earnings (TTM) | €196.31m |
| Revenue (TTM) | €1.03b |
19.4x
P/E Ratio3.7x
P/S RatioIs PBV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PBV income statement (TTM) | |
|---|---|
| Revenue | US$1.12b |
| Cost of Revenue | US$493.11m |
| Gross Profit | US$625.12m |
| Other Expenses | US$411.19m |
| Earnings | US$213.94m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.32 |
| Gross Margin | 55.90% |
| Net Profit Margin | 19.13% |
| Debt/Equity Ratio | 55.5% |
How did PBV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/19 09:10 |
| End of Day Share Price | 2025/03/19 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Prestige Consumer Healthcare Inc. is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Olivia Tong Cheang | BofA Global Research |
| Linda Bolton-Weiser | B. Riley Securities, Inc. |
| Susan Anderson | Canaccord Genuity |